EMPOWER LUNG-3 Study of Chemoimmunotherapy in Advanced NSCLC

Key opinion leaders discuss data from the EMPOWER-Lung-3 study investigating the use of cemiplimab plus chemotherapy in both squamous and non-squamous NSCLC.

Related Videos
View All
Related Content